VirulenceMicrobiologyPeer-reviewed journal article
The T-type voltage-gated Ca2+ channel CaV3.1 as a candidate receptor for Pasteurella multocida toxin and contributes to the disruption of respiratory epithelial barrier induced by the toxin
Haixin Bi, Fei WangiD, Lin LiniD, Dajun ZhangiD, Menghan CheniD, Yuyao Shang, Lin HuaiD, Huanchun CheniD, Bin WuiD, Zhong PengiD
- Citations
- 2
- FWCI
- 0.92
- Field percentile
- top 32%
Abstract
Pasteurella multocida toxin (PMT) is an exotoxin produced by several members of the zoonotic respiratory pathogen P. multocida. The role of PMT in disrupting the mammalian respiratory barrier remains to be elucidated. In this study, we discovered that inoculation of recombinantly expressed PMT increased the permeability of the respiratory epithelial barrier in mouse and respiratory cell models. This was evidenced by a decreased expression of tight junctions (ZO-1, occludin) and adherens junctions ({beta}-catenin, E-cadherin), as well as enhanced cytoskeletal rearrangement. In mechanism, we demonstrated that PMT inoculation induced cytoplasmic Ca2+ inflow, leading to an imbalance of cellular Ca2+ homeostasis and endoplasmic reticulum stress. This process further stimulated the RhoA/ROCK signaling, promoting cytoskeletal rearrangement and reducing the expression of tight junctions and adherens junctions. Notably, the T-type voltage-gated Ca2+ channel CaV3.1 was found to participate in PMT-induced cytoplasmic Ca2+ inflow. Knocking out CaV3.1 significantly reduced the cytotoxicity induced by PMT on swine respiratory epithelial cells and mitigated cytoplasmic Ca2+ inflow stimulated by PMT. Further analysis identified Ser (aa92), Glu (aa155), Tyr (aa167), and Leu (aa448) as crucial sites utilized by PMT to interact with CaV3.1. These findings suggest CaV3.1 serves as an important host receptor of PMT and contributes to PMT-induced respiratory epithelial barrier disruption. ImportancePMT is a significant toxin produced by the zoonotic respiratory pathogen P. multocida, yet little is known about its pathogenesis beyond causing progressive atrophic rhinitis in pigs. In our study, we have discovered that PMT has the capacity to disrupt the integrity of the mammalian respiratory epithelial barrier. This disruption involves an imbalance in cellular Ca2+ homeostasis, endoplasmic reticulum stress, and activation of the RhoA/ROCK signaling pathway induced by PMT. Importantly, we have identified CaV3.1 as a pivotal receptor that plays a crucial role in the pathogenic effects of PMT. Our findings highlight the potential of CaV3.1 as a target for intervention strategies aimed at combating the detrimental effects of PMT.
- organism: mouse
- organism: rat
- organism: non-human primate
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome wide CRISPR screen for Pasteurella multocida toxin (PMT) binding proteins reveals LDL Receptor Related Protein1 (LRP1) as crucial cellular receptor
G. Schmidt, J. Schoellkopf, … J. Orth·bioRxiv·Aug 4, 2022
- Vascular endothelial growth factor A contributes to the increasing of mammalian respiratory epithelial permeability induced by Pasteurella multocida infection
- Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin
- The Bordetella effector protein BteA induces host cell death by disruption of calcium homeostasis
Martin Zmuda, Eliska Sedlackova, … Jana Kamanová·mBioPeer-reviewed·Nov 21, 2024
- Characterization of Outer Membrane β-barrel Proteins of Pasteurella multocida for Multi-Epitope Vaccine Design against Human Pasteurellosis
Amisha Panda, Jahnvi Kapoor, … Anannya Bandyopadhyay·bioRxiv·Sep 15, 2026
- Limited response of primary nasal epithelial cells to Bordetella pertussis infection and the effector protein BteA
Martin Zmuda, Barbora Pravdova, … Jana Kamanová·bioRxiv·Feb 3, 2025